TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30973547

Group type: EXPERIMENTAL
Intervention: +NENS (nutrition education and nutrition supplements)
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: +NS (nutrition supplements)
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: +NS (nutrition supplements) and +NENS (nutrition education and nutrition supplements)
Number of subjects: 600

Group type: COMPARATOR
Intervention: +SE (standard education alone)
Number of subjects: 600
Study: 29334582

Group type: EXPERIMENTAL
Intervention: Carbohydrate mouth rinse (8% maltodextrin)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo rinse (PLA)
Number of subjects: 13
Study: 26687921

Group type: EXPERIMENTAL
Intervention: Conceptual fear-related information (I)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Perceptual cues (C)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Combination of both (CI)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Physiological parameters
Number of subjects: 48
Study: 23135690

Group type: EXPERIMENTAL
Intervention: Tidal volume of 10 mL/kg‐1 at a rate of 10 breaths/minute (Group 10)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Tidal volume of 5 mL/kg‐1 with 5 cmH2O PEEP at a rate of 20 breaths/minute (Group 5)
Number of subjects: 100
Study: 20616415

Group type: EXPERIMENTAL
Intervention: Grape seed extract (GSE)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Vitamin C
Number of subjects: 30
Study: 18484415

Group type: EXPERIMENTAL
Intervention: 2 g vitamin C
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 16368837

Group type: EXPERIMENTAL
Intervention: Sitting position during initiation of small-dose combined spinal-epidural anesthesia (CSE)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Lateral position during initiation of small-dose combined spinal-epidural anesthesia (CSE)
Number of subjects: 60
Study: 14576510

Group type: EXPERIMENTAL
Intervention: Irbesartan 150 mg once daily (increased to 300 mg if necessary)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Amlodipine 5 mg once daily (increased to 10 mg if necessary)
Number of subjects: 60
Study: 11004326

Group type: EXPERIMENTAL
Intervention: Intermittent ceftazidime infusion
Number of subjects: 31

Group type: COMPARATOR
Intervention: Continuous ceftazidime infusion
Number of subjects: 31
Study: 8817536

Group type: EXPERIMENTAL
Intervention: Blind subjects (early blind)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Blindfolded sighted subjects
Number of subjects: 10
Study: 1451928

Group type: EXPERIMENTAL
Intervention: Original product (Duocid)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Generic formulation
Number of subjects: 20
Study: 3711028

Group type: EXPERIMENTAL
Intervention: Haloperidol (1, 2, and 5 mg/day for 2 weeks)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Thioridazine (25, 50, and 75 mg/day for 2 weeks)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 16

Group type: COMPARATOR
Intervention: Thioridazine
Number of subjects: 16
Study: 29763659

Group type: EXPERIMENTAL
Intervention: BGF MDI 160/14.4/10 μg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: BGF MDI 320/14.4/10 μg
Number of subjects: 20

Group type: COMPARATOR
Intervention: BGF MDI 160/14.4/10 μg and BGF MDI 320/14.4/10 μg
Number of subjects: 20
Study: 27605034

Group type: EXPERIMENTAL
Intervention: Cognitive remediation (CR) - strategy-based and drill-and-practice
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Cognitive remediation (CR)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 75
Study: 25140909

Group type: EXPERIMENTAL
Intervention: GSK1265744 LA 800 mg IM
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: GSK1265744 LA
Number of subjects: 8
Study: 22334087

Group type: EXPERIMENTAL
Intervention: Pro-ED blog
Number of subjects: 421

Group type: EXPERIMENTAL
Intervention: Self-help blog
Number of subjects: 421

Group type: COMPARATOR
Intervention: Neutral control blog
Number of subjects: 421
Study: 19671948

Group type: EXPERIMENTAL
Intervention: Increased urinary iodine
Number of subjects: 997

Group type: EXPERIMENTAL
Intervention: Goiter presence
Number of subjects: 997

Group type: EXPERIMENTAL
Intervention: Positive anti-TPO antibodies
Number of subjects: 997

Group type: EXPERIMENTAL
Intervention: Median urinary iodine
Number of subjects: 997
Study: 17681307

Group type: EXPERIMENTAL
Intervention: Vaginal misoprostol (400 microg)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Oral misoprostol (400 microg)
Number of subjects: 77
Study: 20057257

Group type: EXPERIMENTAL
Intervention: Community-based medication reconciliation (CMR) system, involving a clinical pharmacist visiting patients' homes within 72 hours of hospital discharge.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Community-based medication reconciliation (CMR) system
Number of subjects: 0
Study: 15928790

Group type: EXPERIMENTAL
Intervention: Cognitive remediation and work therapy
Number of subjects: 0
Study: 11319626

Group type: EXPERIMENTAL
Intervention: SSM+ (semisolid meal with modified guar gum)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: SSM (semisolid meal without modified guar gum)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: SM (solid meal)
Number of subjects: 28
Study: 9386662

Group type: EXPERIMENTAL
Intervention: PRISM III-APS score
Number of subjects: 11165

Group type: COMPARATOR
Intervention: PRISM III
Number of subjects: 11165
Study: 8427664

Group type: EXPERIMENTAL
Intervention: Tricuff (Pressure Group AB, Stockholm)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Large standard cuff (rubber bag 12 x 35 cm)
Number of subjects: 20
Study: 3105986

Group type: EXPERIMENTAL
Intervention: Human Insulin (HI)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Porcine Insulin (PI)
Number of subjects: 21
Study: 12095665

Group type: COMPARATOR
Intervention: 0 mg (placebo)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 50 mg of oral cocaine HCl
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 100 mg of oral cocaine HCl
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 150 mg of oral cocaine HCl
Number of subjects: 8
Study: 29901753

Group type: EXPERIMENTAL
Intervention: 1000 µg folic acid daily (as part of a multivitamin) throughout pregnancy and lactation until 8 weeks postpartum
Number of subjects: 117
Study: 25744954

Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI) with personalized feedback
Number of subjects: 98

Group type: COMPARATOR
Intervention: Interactive education
Number of subjects: 98
Study: 24266524

Group type: EXPERIMENTAL
Intervention: Facilitated tucking position during suctioning
Number of subjects: 34

Group type: COMPARATOR
Intervention: Suctioning without intervention
Number of subjects: 34
Study: 22330010

Group type: EXPERIMENTAL
Intervention: Verum acupuncture
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional analgesia (oral diclofenac and metamizol, local lidocaine)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 50
Study: 20141299

Group type: EXPERIMENTAL
Intervention: Mindfulness Training (MT) for 8 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waitlisted controls
Number of subjects: 0
Study: 18525491

Group type: EXPERIMENTAL
Intervention: 1-level kyphoplasty
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: 2 or 3-level kyphoplasty
Number of subjects: 27
Study: 16002829

Group type: EXPERIMENTAL
Intervention: Higher-protein diets
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lower-protein diets
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Increased protein intake
Number of subjects: 0
Study: 12443525

Group type: EXPERIMENTAL
Intervention: Neurophysiological facilitation
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Passive movement
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Sensory stimulation
Number of subjects: 13

Group type: COMPARATOR
Intervention: No intervention (control)
Number of subjects: 13
Study: 10513865

Group type: EXPERIMENTAL
Intervention: Ondansetron (2.0 mL = 4.0 mg)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Normal saline (2.0 mL)
Number of subjects: 50
Study: 7725371

Group type: EXPERIMENTAL
Intervention: Systematic approach to individualizing phenytoin dose based on one-point, steady-state plasma concentration
Number of subjects: 35
Study: 2143960

Group type: EXPERIMENTAL
Intervention: Aminoglutethimide + Hydrocortisone (AG + HC)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Medroxyprogesterone Acetate + Hydrocortisone (MPA + HC)
Number of subjects: 59
Study: 6156412

Group type: EXPERIMENTAL
Intervention: 20 g i.v. gammaglobulin (Intraglobin)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group (without gammaglobulin)
Number of subjects: 150
Study: 29514847

Group type: EXPERIMENTAL
Intervention: Consumer-driven product materials provided at the point of sale
Number of subjects: 836

Group type: COMPARATOR
Intervention: Standard information provided at the point of sale (Control)
Number of subjects: 836
Study: 28941144

Group type: EXPERIMENTAL
Intervention: BNP levels in HFrEF patients
Number of subjects: 288

Group type: EXPERIMENTAL
Intervention: BNP levels in HFrlEF patients
Number of subjects: 288

Group type: EXPERIMENTAL
Intervention: BNP levels in HFrhEF patients
Number of subjects: 288
Study: 26953235

Group type: EXPERIMENTAL
Intervention: Acupuncture combined with usual care (12-16 sessions of manual acupuncture±electroacupuncture over 6 weeks)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Usual care alone (control group)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Acupuncture combined with usual care
Number of subjects: 50
Study: 23864286

Group type: COMPARATOR
Intervention: Training experienced anatomy teachers in the use of the one-minute preceptor (OMP) technique.
Number of subjects: 152

Group type: COMPARATOR
Intervention: Experienced teachers' own approaches (not using OMP).
Number of subjects: 152
Study: 23141074

Group type: EXPERIMENTAL
Intervention: Visual-to-auditory sensory-substitution algorithm (soundscapes)
Number of subjects: 0
Study: 20496567

Group type: EXPERIMENTAL
Intervention: Ofloxacin regimen (28 daily doses of rifampicin 600mg + ofloxacin 400mg + 5 months placebo)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Standard WHO-MDT regimen (6-month treatment)
Number of subjects: 124
Study: 18031971

Group type: EXPERIMENTAL
Intervention: Additional care by a pulmonary nurse (protocol‐based education program, average duration 60 min per patient)
Number of subjects: 191

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 191
Study: 15975149

Group type: EXPERIMENTAL
Intervention: CD14 -159CC genotype
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Plasma sCD14 levels
Number of subjects: 45
Study: 12582353

Group type: EXPERIMENTAL
Intervention: Cancellous cores (CC) harvested through a 0.5- to 1.0-cm incision with a motor-driven trephine
Number of subjects: 76

Group type: COMPARATOR
Intervention: Corticocancellous block grafts (CCBG) harvested by traditional open medial approach
Number of subjects: 76
Study: 10749335

Group type: EXPERIMENTAL
Intervention: 3 megaunits (MU) of human lymphoblastoid IFN six days per week for two weeks, followed by three days per week for 50 weeks
Number of subjects: 35

Group type: COMPARATOR
Intervention: 6 MU six days per week for two weeks followed by three days per week for 24 weeks
Number of subjects: 35
Study: 8751521

Group type: EXPERIMENTAL
Intervention: Normothermia (n = 68)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Hypothermia (n = 70)
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 138
Study: 1431009

Group type: EXPERIMENTAL
Intervention: Paroxetine 20 mg daily (increased at week 3 if necessary)
Number of subjects: 309

Group type: COMPARATOR
Intervention: Amitriptyline 75 mg daily in divided doses (increased at week 3 if necessary)
Number of subjects: 309
Study: 4034823

Group type: EXPERIMENTAL
Intervention: Covert positive reinforcement
Number of subjects: 80

Group type: COMPARATOR
Intervention: Backward conditioning
Number of subjects: 80

Group type: COMPARATOR
Intervention: Covert rehearsal
Number of subjects: 80

Group type: COMPARATOR
Intervention: Expectancy conditions
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Self-generated coping strategies
Number of subjects: 80
Study: 30892294

Group type: EXPERIMENTAL
Intervention: 3Y-TZP (group A)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 4Y-TZP (group B)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 5Y-TZP (group C)
Number of subjects: 48
Study: 28504315

Group type: EXPERIMENTAL
Intervention: Exposure to a suicide news article with psychoeducational information and preventative resources
Number of subjects: 0

Group type: COMPARATOR
Intervention: Exposure to a suicide news article without psychoeducational information and preventative resources
Number of subjects: 0
Study: 27283370

Group type: EXPERIMENTAL
Intervention: Tenotomy (group I)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Tenodesis (group II)
Number of subjects: 128
Study: 24390800

Group type: EXPERIMENTAL
Intervention: Radiofrequency surgery of the soft palate
Number of subjects: 35

Group type: COMPARATOR
Intervention: Sham surgery of the soft palate
Number of subjects: 35
Study: 23121473

Group type: EXPERIMENTAL
Intervention: Vildagliptin + metformin
Number of subjects: 171

Group type: COMPARATOR
Intervention: Placebo + metformin
Number of subjects: 171
Study: 20099946

Group type: EXPERIMENTAL
Intervention: Past-year mood disorder
Number of subjects: 1504

Group type: EXPERIMENTAL
Intervention: Ever diagnosed anxiety disorder
Number of subjects: 1504

Group type: EXPERIMENTAL
Intervention: Ever diagnosed with more than one psychiatric diagnosis
Number of subjects: 1504

Group type: COMPARATOR
Intervention: Never diagnosed group
Number of subjects: 1504
Study: 18513646

Group type: EXPERIMENTAL
Intervention: Intracoronary bone marrow cell (BMC) transplantation (1 x 10^8 cells)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group (no BMC treatment)
Number of subjects: 62
Study: 15742825

Group type: COMPARATOR
Intervention: Caffeine gum 0 mg (placebo)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Caffeine gum 100 mg (low dose)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Caffeine gum 300 mg (high dose)
Number of subjects: 9
Study: 12095806

Group type: EXPERIMENTAL
Intervention: Trimethoprim (160 mg)/sulfamethoxazole (800 mg) every 3 days (61 patients)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Observation without treatment (63 patients)
Number of subjects: 124
Study: 9827404

Group type: EXPERIMENTAL
Intervention: Postoperative thromboprophylaxis consensus
Number of subjects: 505

Group type: EXPERIMENTAL
Intervention: Lower than recommended heparin dosage
Number of subjects: 505

Group type: EXPERIMENTAL
Intervention: General anesthesia
Number of subjects: 505

Group type: EXPERIMENTAL
Intervention: Age over 70 years
Number of subjects: 505

Group type: EXPERIMENTAL
Intervention: Reduced mobility
Number of subjects: 505
Study: 8018619

Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.5%
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 60
Study: 2684551

Group type: EXPERIMENTAL
Intervention: Slow-release oral ketotifen (2 mg daily for 12 weeks)
Number of subjects: 245

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Slow-release oral ketotifen
Number of subjects: 245
Study: 1152627

Group type: EXPERIMENTAL
Intervention: Running (n = 9)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Walking (n = 9)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Bicycling (n = 8)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control (n = 7)
Number of subjects: 35
Study: 30004123

Group type: EXPERIMENTAL
Intervention: 1 g/day n3‐PUFA
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 4 g/day n3‐PUFA
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 27824434

Group type: EXPERIMENTAL
Intervention: Liposomal bupivacaine 266 mg/20 mL (admixed with standard bupivacaine 0.5% 20 mL)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bupivacaine 0.5% 20 mL
Number of subjects: 0
Study: 25391338

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 880

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 880
Study: 22683226

Group type: EXPERIMENTAL
Intervention: Zonisamide 100 mg/day up-titrated to 300 mg/day
Number of subjects: 583

Group type: COMPARATOR
Intervention: Controlled-release carbamazepine 200 mg/day up-titrated to 600 mg/day
Number of subjects: 583

Group type: EXPERIMENTAL
Intervention: Zonisamide
Number of subjects: 583

Group type: COMPARATOR
Intervention: Controlled-release carbamazepine
Number of subjects: 583
Study: 20453627

Group type: EXPERIMENTAL
Intervention: DOT‐ART
Number of subjects: 274
Study: 18822982

Group type: EXPERIMENTAL
Intervention: Electroacupuncture combined with local blocking therapy
Number of subjects: 100

Group type: COMPARATOR
Intervention: Oral administration of 25 mg Indomethacin thrice daily and 100 mg Allopurinol thrice daily
Number of subjects: 100
Study: 15621991

Group type: EXPERIMENTAL
Intervention: Lapband
Number of subjects: 180

Group type: COMPARATOR
Intervention: SAGB
Number of subjects: 180
Study: 11865962

Group type: EXPERIMENTAL
Intervention: New intravenous varicella zoster immune globulin (VZIG)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Standard intramuscular varicella zoster immune globulin (VZIG)
Number of subjects: 57
Study: 10526698

Group type: EXPERIMENTAL
Intervention: Beta blockers (lipophilic agents such as timolol, metoprolol, propranolol, bisoprolol, and carvedilol)
Number of subjects: 55000

Group type: EXPERIMENTAL
Intervention: Beta blockers (lipophilic agents)
Number of subjects: 55000
Study: 7839425

Group type: EXPERIMENTAL
Intervention: Triple-drug therapy (cyclosporine, azathioprine, and prednisolone)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Double-drug therapy (azathioprine and prednisolone)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Triple-drug to double-drug therapy conversion
Number of subjects: 34
Study: 2495049

Group type: EXPERIMENTAL
Intervention: Ketanserin (20 mg three times daily for the first month, then 40 mg three times daily thereafter)
Number of subjects: 3899

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3899

Group type: EXPERIMENTAL
Intervention: Ketanserin (after excluding patients taking potassium losing diuretics)
Number of subjects: 3899

Group type: COMPARATOR
Intervention: Placebo (after excluding patients taking potassium losing diuretics)
Number of subjects: 3899
Study: 605770

Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 107

Group type: COMPARATOR
Intervention: Halothane
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Both
Number of subjects: 107
Study: 7043304

Group type: EXPERIMENTAL
Intervention: Iohexol 300 mg I/ml
Number of subjects: 27

Group type: COMPARATOR
Intervention: Conray meglumine 282 mg I/ml
Number of subjects: 27

Group type: COMPARATOR
Intervention: Amipaque 300 mg I/ml
Number of subjects: 27
Study: 31806484

Group type: EXPERIMENTAL
Intervention: Open Reduction and Internal Fixation (ORIF)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Maxillo‐mandibular fixation (MMF)
Number of subjects: 40
Study: 31420131

Group type: EXPERIMENTAL
Intervention: Foot-support
Number of subjects: 19

Group type: COMPARATOR
Intervention: Forward tilted seating (FW)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Horizontal seat
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Foot-support with horizontal seat
Number of subjects: 19
Study: 30600733

Group type: EXPERIMENTAL
Intervention: Histopathology diagnosis of MC
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Histopathology diagnosis of collagenous colitis (CC)
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Histopathology diagnosis of lymphocytic colitis (LC)
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Symptoms of MC
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Stool culture
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Celiac serology
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Other autoimmune diseases
Number of subjects: 211
Study: 29282954

Group type: EXPERIMENTAL
Intervention: Sacrococcygeal massage therapy, 3 times a week for 2 weeks
Number of subjects: 184

Group type: COMPARATOR
Intervention: Diclofenac Diethylamine Emulgel, 2 times a day for 2 weeks
Number of subjects: 184
Study: 25218839

Group type: EXPERIMENTAL
Intervention: Riata patients
Number of subjects: 299

Group type: COMPARATOR
Intervention: Nonadvisory controls
Number of subjects: 299
Study: 22050449

Group type: EXPERIMENTAL
Intervention: Omeprazole (20 mg once daily) plus sodium alginate (30 mL four times a day)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Omeprazole (20 mg once daily) alone
Number of subjects: 76
Study: 18836704

Group type: EXPERIMENTAL
Intervention: 40 microg CCK‐8S
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 17505072

Group type: EXPERIMENTAL
Intervention: Oral sodium clodronate (2080 mg/day)
Number of subjects: 508

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 508
Study: 14871425

Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 0

Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SUA as a time-varying covariate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SUA in women
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SUA in men
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Treatment effect of losartan on primary composite endpoint
Number of subjects: 0
Study: 12397463

Group type: COMPARATOR
Intervention: FTD patients (n=8)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: AD patients (n=21)
Number of subjects: 29
Study: 9836031

Group type: EXPERIMENTAL
Intervention: Sevoflurane 7.5% in nitrous oxide 67% in oxygen
Number of subjects: 67

Group type: COMPARATOR
Intervention: Isoflurane 3.5% in nitrous oxide 67% in oxygen
Number of subjects: 67
Study: 8021761

Group type: EXPERIMENTAL
Intervention: Recombinant IFN-alpha (3 million units per square meter of body surface area, three times a week for 15 months)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control (untreated subjects)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Recombinant IFN-alpha
Number of subjects: 65
Study: 2920318

Group type: COMPARATOR
Intervention: Latex catheter
Number of subjects: 100

Group type: COMPARATOR
Intervention: Silicone catheter
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Closed urinary drainage system with strict sterile conditions and meticulous ongoing catheter care
Number of subjects: 100
Study: 1101758

Group type: EXPERIMENTAL
Intervention: Naproxen
Number of subjects: 80

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 80